Clinical Trials Logo

Opiate Dependence clinical trials

View clinical trials related to Opiate Dependence.

Filter by:

NCT ID: NCT00475878 Completed - Depression Clinical Trials

SSRI and Buprenorphine

Start date: December 2006
Phase: Phase 3
Study type: Interventional

This study is designed to test whether treatment of depressive symptoms using escitalopram improves adherence to Buprenorphine and reduces symptoms of depression for individuals receiving Buprenorphine through their medical provider.

NCT ID: NCT00439036 Completed - Opiate Dependence Clinical Trials

Acceptance Therapy During Methadone Detoxification

Start date: July 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to develop an opiate detoxification behavior therapy based on current Acceptance and Commitment Therapy (ACT) theory and method, and to test its feasibility and promise in the context of voluntary methadone detoxification.

NCT ID: NCT00406484 Completed - HIV Infections Clinical Trials

Brief Introductory Therapy for Opioid Dependence

Start date: September 2004
Phase: Phase 2
Study type: Interventional

A randomized clinical trial to compare the efficacy of Behavioral Drug and HIV Risk Reduction Counseling (BDRC) and standard methadone drug counseling.

NCT ID: NCT00383045 Completed - Opiate Dependence Clinical Trials

HIV Risk Reduction and Drug Abuse Treatment in Malaysia

Start date: April 2003
Phase: Phase 2
Study type: Interventional

A randomized clinical trial comparing drug abuse and HIV risk reduction counseling (DC-HIV) alone, DC-HIV combined with naltrexone maintenance, and DC-HIV combined with buprenorphine maintenance for the treatment of heroin addicts in Malaysia.

NCT ID: NCT00367874 Completed - Opiate Dependence Clinical Trials

Treatment of Polydrug-Using Opiate Dependents During Withdrawal

Start date: February 2003
Phase: Phase 4
Study type: Interventional

Managed detoxification is a first and necessary step prior to treatment and rehabilitation. Detoxification can be a major obstacle for some patients, and the availability of managed and safe withdrawal is a prerequisite for long-term treatment. In our clinical practice we have felt the need for a standardised and safe detoxification treatment regimen for our opioid addicts, as dependence on multiple drugs is so common. Objectives 1. To assess whether a novel standardised treatment regimen - Buprenorphine (BPN) combined with Valproate (VPA) - will result in fewer withdrawal symptoms during detoxification of opiate–polydrug users than the existing treatment regimen, i.e. Clonidine (CLN) combined with Carbamazepine (CBZ). 2. To determine whether there are differences in treatment retention between the BPN/VPA and the CLN/CBZ groups. 3. To assess differences in clinical side-effects and biochemical interactions between the two treatment regimens.

NCT ID: NCT00332228 Completed - Opiate Dependence Clinical Trials

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

Start date: June 2002
Phase: Phase 2
Study type: Interventional

The overall goal of this research project is to test the efficacy of a newly developed therapy, Behavioral Naltrexone Therapy (BNT), to enhance the success of naltrexone maintenance and long-term abstinence for individuals with heroin dependence. This study includes free detox and outpatient treatment for opioid dependence that includes medication and a behavioral intervention.

NCT ID: NCT00316277 Completed - Clinical trials for Substance-related Disorders

Prescription Opioid Addiction Treatment Study (POATS)

Start date: May 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether treatment outcome for subjects dependent on prescription opioid analgesics can be improved by adding individual drug counseling to the prescription of buprenorphine/naloxone with standard medical management. This will be examined during: a) an initial four-week treatment with taper; b) a 12-week stabilization treatment for those who do not respond successfully to the initial treatment; and c) a long-term follow-up assessment at 1.5 years, 2.5 years, and 3.5 years after treatment.

NCT ID: NCT00300794 Completed - Opiate Dependence Clinical Trials

Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia

Start date: February 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether low-dose ketamine infusion is effective in suppressing the symptoms of opiate withdrawal during rapid opiate antagonist induction (RAI).

NCT ID: NCT00241943 Completed - Hepatitis C Clinical Trials

A Video-Based HCV Curriculum for Active Injection Drug Users

Start date: November 2005
Phase: N/A
Study type: Interventional

The investigators hypothesize that a well-designed hepatitis C (HCV) video education curriculum for active drug injectors will lead to measurable improvements in HCV testing rates, HAV and HBV vaccination rates, as well as knowledge and attitudes about this condition. The investigators will use a short 10 minute video designed for active drug users to and assess its impact vs. a usual-care counseling intervention. The investigators will measure and compare its impact at baseline, 4 weeks after video viewing, and 12 weeks after intervention.

NCT ID: NCT00241917 Completed - Hepatitis C Clinical Trials

A Video-Based HCV Curriculum for Drug Users

Start date: November 2005
Phase: N/A
Study type: Interventional

The investigators hypothesize that a well-designed hepatitis C (HCV)video education curriculum for high-risk drug users will show measurable benefits in improving HCV testing, hepatitis A and B vaccinations, and HCV knowledge, attitudes, and motivations toward transmission behavior change. The investigators will use a 4-part modular video series designed for at-risk drug users, and in this 12 week study will assess its impact on testing/vaccinations as well as knowledge, attitudes, and motivations in methadone-maintained drug users as compared to a usual-care intervention.